These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12837479)

  • 1. The release profiles of intact and enzymatically digested hyaluronic acid from semisolid formulations using multi-layer membrane system.
    Alkrad JA; Mrestani Y; Neubert RH
    Eur J Pharm Biopharm; 2003 Jul; 56(1):37-41. PubMed ID: 12837479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Liberation of hydrocortisone acetate from different commercial formulations].
    Neubert RH; Pötzsch A
    Pharmazie; 2004 Jun; 59(6):472-4. PubMed ID: 15248463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability determination of the formulations containing hyaluronic acid.
    Olejnik A; Goscianska J; Zielinska A; Nowak I
    Int J Cosmet Sci; 2015 Aug; 37(4):401-7. PubMed ID: 25704548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New approaches for quantifying hyaluronic acid in pharmaceutical semisolid formulations using HPLC and CZE.
    Alkrad JA; Merstani Y; Neubert RH
    J Pharm Biomed Anal; 2002 Nov; 30(4):913-9. PubMed ID: 12408880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Penetration profile of taurine in the human skin and its distribution in skin layers.
    da Silva DL; Thiago SB; Pessôa FA; Mrestani Y; Rüttinger HH; Wohlrab J; Neubert RH
    Pharm Res; 2008 Aug; 25(8):1846-50. PubMed ID: 18438702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The "bubble point" for validation of drug release or simulated absorption tests for ointments.
    Realdon N; Tagliaboschi A; Perin F; Ragazzi E
    Pharmazie; 2005 Dec; 60(12):910-6. PubMed ID: 16398267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative permeation studies of nondiluted and diluted betamethasone-17-valerate semisolid formulations through isolated human stratum corneum and artificial skin construct.
    Mitriaikina S; Muller-Goymann CC
    Skin Pharmacol Physiol; 2009; 22(3):142-50. PubMed ID: 19246962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amphiphilic hyaluronic acid derivatives toward the design of micelles for the sustained delivery of hydrophobic drugs.
    Mayol L; Biondi M; Russo L; Malle BM; Schwach-Abdellaoui K; Borzacchiello A
    Carbohydr Polym; 2014 Feb; 102():110-6. PubMed ID: 24507262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of in-vitro release characteristics of carbamazepine extended release semisolid matrix filled capsules based on Gelucires.
    Galal S; El Massik MA; Abdallah OY; Daabis NA
    Drug Dev Ind Pharm; 2004 Sep; 30(8):817-29. PubMed ID: 15521328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of sodium hyaluronate-based intranasal formulations containing micro- or nanosized meloxicam particles.
    Bartos C; Ambrus R; Sipos P; Budai-Szűcs M; Csányi E; Gáspár R; Márki Á; Seres AB; Sztojkov-Ivanov A; Horváth T; Szabó-Révész P
    Int J Pharm; 2015 Aug; 491(1-2):198-207. PubMed ID: 26142244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New sustained-release intraarticular gel formulations based on monolein for local treatment of arthritic diseases.
    Réeff J; Gaignaux A; Goole J; De Vriese C; Amighi K
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1731-41. PubMed ID: 23078519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of gelatin-acacia coacervate containing benzocaine in topical formulations.
    Ichwan AM; Karimi M; Dash AK
    J Pharm Sci; 1999 Aug; 88(8):763-6. PubMed ID: 10430539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and evaluation of an artificial membrane for determination of drug availability.
    Loftsson T; Konrádsdóttir F; Másson M
    Int J Pharm; 2006 Dec; 326(1-2):60-8. PubMed ID: 16920289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supramolecular organization and release properties of phospholipid-hyaluronan microparticles encapsulating dexamethasone.
    Gómez-Gaete C; Tsapis N; Silva L; Bourgaux C; Besnard M; Bochot A; Fattal E
    Eur J Pharm Biopharm; 2008 Sep; 70(1):116-26. PubMed ID: 18585906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo evaluation of two new sustained release formulations elaborated by one-step melt granulation: level A in vitro-in vivo correlation.
    Ochoa L; Igartua M; Hernández RM; Solinís MA; Gascón AR; Pedraz JL
    Eur J Pharm Biopharm; 2010 Jun; 75(2):232-7. PubMed ID: 20159037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro availability of kaempferol glycosides from cream formulations of methanolic extract of the leaves of Melilotus elegans.
    Gebre-Mariam T; Asres K; Getie M; Endale A; Neubert R; Schmidt PC
    Eur J Pharm Biopharm; 2005 May; 60(1):31-8. PubMed ID: 15848053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled drug release from cross-linked κ-carrageenan/hyaluronic acid membranes.
    El-Aassar MR; El Fawal GF; Kamoun EA; Fouda MM
    Int J Biol Macromol; 2015; 77():322-9. PubMed ID: 25840148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro release testing method development for ophthalmic ointments.
    Bao Q; Shen J; Jog R; Zhang C; Newman B; Wang Y; Choi S; Burgess DJ
    Int J Pharm; 2017 Jun; 526(1-2):145-156. PubMed ID: 28461266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Semisolid matrix filled capsules: an approach to improve dissolution stability of phenytoin sodium formulation.
    El Massik MA; Abdallah OY; Galal S; Daabis NA
    Drug Dev Ind Pharm; 2003 May; 29(5):531-43. PubMed ID: 12779283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ointment vehicles regulate the wound-healing process by modifying the hyaluronan-rich matrix.
    Murasawa Y; Furuta K; Noda Y; Nakamura H; Fujii S; Isogai Z
    Wound Repair Regen; 2018 Nov; 26(6):437-445. PubMed ID: 30252184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.